Search

9025 results for: ‘(完善版)TP开发源码交易系统 网站交易 域名交易 任务交易 自助交易系统 非友价源码✅项目合作 二开均可 TG:saolei44✅.kbwIoWOkEW’

  • Mr Emmanuel Katsogridakis

    MD, MSc, PhD, MRCS British Heart Foundation Academic Clinical Lecturer Email  ek311@le.ac.

  • Collections and Research

    Read about the collections and research associated with the Botanic Garden.

  • Cerebral Autoregulation

    Impaired regulation of cerebral blood flow is implicated in a number of clinical conditions, such as ischaemic stroke, severe head injury, liver failure, diabetes, autonomic nervous system failure, carotid artery disease, dementia, pre-eclampsia and neonatal prematurity.

  • Dr Robert Owen ‘Toby’ Law

    The University regrets to report the death of Dr Toby Law, who was for more than 30 years a member of academic staff. Toby was appointed to a University Lectureship in 1971 in the then new Department of Physiology (formed in 1968) and in 1987 was promoted to Senior Lecturer.

  • Thick Translation of Chin Ping Mei by David Roy: Type, Function and Features

    Find out more about our event: Thick Translation of Chin Ping Mei by David Roy: Type, Function and Features, with speaker Professor Xiuying Wen.

  • David Coppock

    The academic profile of Mr David Coppock, Doctoral Researcher at University of Leicester

  • Tayyaba Khurram

    The academic profile of Dr Tayyaba Khurram, IODP Technician at University of Leicester

  • TB metabolism

    See more about the impact of studying TB metabolism in the Leicester Microbial Sciences and Infectious Diseases Network.

  • Spotlight on CLANet -- Deep learning in cell line authentication

    CLANet is an AI framework developed by Professor H Zhou's and collaborators, and funded by AstraZeneca Ltd. Cell line authentication plays a crucial role in the biomedical field, ensuring researchers work with accurately identified cells.

  • Medicine offers weight-loss hope for patients with type-2 diabetes

    New research by academics at the University of Leicester published today (Friday) has given fresh hope to patients with type-2 diabetes, after Eli Lilly and Company’s SURPASS-2 clinical trial showed that 60% of patients achieved a 10% percent or greater weight loss with 15 mg...

Back to top
MENU